Table 2.

Metabolic syndrome prevalence by different breast cancer subtypes among postmenopausal women

	MS prevalence	OR	p
LUMINAL (Luminal A + Luminal B)	62.7%	1.37(1.07-2.80)	0.03
LUMINAL A	25.5%	0.71 (0.41-1.21)	0.2
LUMINAL B	37.5%	1.74 (0.99-3.06)	0.06
HER-2+	20%	0.60 (0.19-1.86)	0.38
TN	25.8%	0.85 (0.36-1.0)	0.71